FindTrial
Sign In

Comparison study between chamomile and calendula creams to prevent radiation-induced skin lesions

Comparative study of chamomile and calendula creams in the prevention of radiodermatitis: double blind randomized clinical trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-98myd6
Enrollment
Unknown
Registered
2020-04-03
Start date
2020-02-27
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

wounds and injuries

Interventions

Research participants will apply chamomile cream or calendula topically, in the treatment region, according to the research protocol. The observing researcher will not know which product is being used
Other
B01.650.940.800.575.912.250.100.195
B01.650.940.800.575.912.250.100.141

Sponsors

Daniele Machado Oliveira Andrade
Lead Sponsor
Daniele Machado Oliveira Andrade
Collaborator

Eligibility

Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: Both sexes; age equal to or over 18 years; diagnosis of head and neck cancer

Exclusion criteria

Exclusion criteria: History of radiotherapy in the same field of treatment; previous report of allergic reaction to chamomile or calendula

Design outcomes

Primary

MeasureTime frame
To compose the sample, all patients treated at the two radiotherapy services were considered for a period of 6 (six) months. It is estimated that in this period, based on the history of the services, about 50 patients will be evaluated.—

Secondary

MeasureTime frame
Both groups using chamomile cream and calendula cream are expected to have low incidences in the development of radiodermatitis and skin toxicity grades.—

Countries

Brazil

Contacts

Public ContactDaniele Oliveira Andrade

Universidade Federal do Triângulo Mineiro UFTM

dani.moliv@hotmail.com+55(34) 99874-4035

Outcome results

None listed

Source: REBEC (via WHO ICTRP)